Showing 1 - 10 of 815
This study examines how industry peers share information when they are engaged in tacit collusion. We develop a model … of firms' information sharing and production decisions and use it to establish that firms engaged in tacit collusion are … information sharing when firms place less weight on the future benefit from tacit collusion …
Persistent link: https://www.econbiz.de/10012856190
Clustering of IPO underwriting spreads at 7% poses two important puzzles: Is the market for U.S. equity underwriting services anti-competitive and why do equity underwriters invest in reputation-building? This study resolves both puzzles. Modeling endogeneity of firm-underwriter choice using a...
Persistent link: https://www.econbiz.de/10011334160
Clustering of IPO underwriting spreads at 7% poses two important puzzles: Is the market for U.S. equity underwriting services anti-competitive and why do equity underwriters invest in reputation-building? This study resolves both puzzles. Modeling endogeneity of firm-underwriter choice using a...
Persistent link: https://www.econbiz.de/10012937858
This paper explores the adoption choice of electronic medical records by U.S hospitals, which could exhibit strategic complements or substitutes. I find complementarities in adoption through a reduced-form analysis with instruments for the unobserved market characteristics. I further develop a...
Persistent link: https://www.econbiz.de/10012900282
This paper seeks to understand the incentives of affiliated hospitals in choosing health information technology (IT) vendors. By adopting a system popular in the local market, hospitals may benefit from complementarities but also worry about losing patients. If benefits outweigh the competitive...
Persistent link: https://www.econbiz.de/10012899159
This paper summarizes four stylized facts about the prescription drug markets after patent expiration during the 80s: (i) generic firms entered the market at different points of time after patent expiration and they seldom exited; (ii) the brand-name price remained much higher than generic prices,...
Persistent link: https://www.econbiz.de/10014046066
This paper studies (1) whether, from a welfare point of view, oligopolistic competition leads to too few or too many products in a market, and (2) how a change in competition affects the number and the composition of product offerings. We address these two questions in the context of the U.S....
Persistent link: https://www.econbiz.de/10014141809
We address one of the cardinal puzzles of European corporate law: the lack of derivate shareholder suits. We explain this phenomenon on the basis of percentage limits which require shareholders to hold a minimum amount of shares in order to bring a lawsuit. We show that, under this legal regime,...
Persistent link: https://www.econbiz.de/10008738315
Persistent link: https://www.econbiz.de/10003923624
control drugs. Our analysis highlights (i) the difficulty of establishing a suitable control group when collusion is pervasive … collusion on prices. Our most conservative estimates suggest that collusion led to price increases of between 0% and 166% for …
Persistent link: https://www.econbiz.de/10012670921